Physician profile
Drew Moorman
NPI 1710167473
$2,065.48
in general payments reported to CMS, 2019-2025
17 companies · $306 in 2025
The $306 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $132 · 2021: $226 · 2022: $407 · 2023: $494 · 2024: $309 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $543.04 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $414.52 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $185.30 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $184.13 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sobi, INC | $168.21 | 2022-2024 | |
| Sanofi Pasteur INC. | $119.59 | 2019-2023 | |
| Glaxosmithkline, LLC. | $103.31 | 2019-2023 | Bexsero |
| Supernus Pharmaceuticals, INC. | $95.78 | 2022-2024 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $62.43 | 2025 | Jornay Pm |
| Ars Pharmaceuticals Operations, INC. | $49.10 | 2025 | Neffy |
| Adlon Therapeutics L.P. | $40.47 | 2020-2021 | |
| Tris Pharma INC | $19.49 | 2019 | |
| Medline Industries Lp | $18.33 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.26 | 2020 | |
| Pbg Puerto Rico LLC | $16.49 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $16.15 | 2023 | Flumist Quadrivalent |
| Shire North American Group INC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Moorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.